Categories LATEST

SUV craze brings more investment to Volkswagen’s Tennessee plant

Automaker Volkswagen is planning to invest $340 million at its Chattanooga, Tennessee factory to build a smaller version of its Atlas model — a new five-seater SUV. The name of the new model, which will be the third to be produced at the Tennessee plant, is yet to be revealed.

(Image Courtesy: Wikimedia Commons)

After the Passat, which was the first model built at the plant, the carmaker invested $900 million in building the three-row SUV, Atlas, which started selling last year. A concept of the new five-passenger model will be presented at the New York International Auto Show next week, and its production is expected to start towards the end of 2019.

The new investment points to the assumption that demand for SUVs will continue going forward. Along with the increased investment, more jobs are expected to be created depending on sales volumes at the plant, in addition to the current 3,500 employees.

Over the past two months, SUVs comprised 54% of all Volkswagen brands sales in the U.S. It is estimated that there is more room for sales growth in the SUV segment. Volkswagen currently holds a 2% market share in the U.S., and it aims to increase this figure to 5%.

The Chattanooga plant could one day be the site of electric vehicle production as well. The plant is said to have excess production capacity, and it would be reasonable for the company to produce vehicles in markets that have higher sales potential to lower freight costs and avoid currency fluctuations.

These efforts are part of Volkswagen’s plan to take corrective actions after its struggle following the emissions scandal.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top